COVID-19 IgG/IgM Microfluidic Chip is developed with microfluidic technology, fluorescence technology and indirect immune capture principle of comprehensive detection technology to detect IgG/IgM of SARS-CoV-2 in human serum, plasma and whole blood. Microfluidic technology is a detection technology that uses the microchannel inside the reagent cartridge to realize liquid quantification and uniform flow. The test kit is used in combination with NewScen Fluorimetric Immunoassay Analyser F10Pro.

Features :

• Test result obtained within 4 minutes
• Maximum 15 days room temperature transportation
• Micro sampling, 5μL serum/plasma or 10μL whole blood
• Continuous operations & simultaneous reactions outside the analyzer